U.S. markets open in 5 hours 14 minutes
  • S&P Futures

    3,376.25
    +24.25 (+0.72%)
     
  • Dow Futures

    27,889.00
    +225.00 (+0.81%)
     
  • Nasdaq Futures

    11,485.50
    +78.25 (+0.69%)
     
  • Russell 2000 Futures

    1,516.60
    +12.20 (+0.81%)
     
  • Crude Oil

    39.92
    -0.30 (-0.75%)
     
  • Gold

    1,901.60
    +6.10 (+0.32%)
     
  • Silver

    23.77
    +0.28 (+1.17%)
     
  • EUR/USD

    1.1743
    +0.0017 (+0.14%)
     
  • 10-Yr Bond

    0.6770
    0.0000 (0.00%)
     
  • Vix

    25.74
    -0.53 (-2.02%)
     
  • GBP/USD

    1.2891
    -0.0030 (-0.23%)
     
  • USD/JPY

    105.5290
    +0.0990 (+0.09%)
     
  • BTC-USD

    10,864.41
    +68.38 (+0.63%)
     
  • CMC Crypto 200

    234.13
    +12.73 (+5.75%)
     
  • FTSE 100

    5,914.74
    +48.64 (+0.83%)
     
  • Nikkei 225

    23,184.93
    -0.19 (-0.00%)
     

Mitcham Industries's Q2 Earnings Outlook

Benzinga Newsdesk

Mitcham Industries (NASDAQ: MIND) releases its next round of earnings this Wednesday. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.

Earnings and Revenue

Mitcham Industries EPS will likely be near a loss of 49 cents while revenue will be around $8 million, according to analysts.

View more earnings on MIND

In the same quarter last year, Mitcham Industries posted an EPS loss of 46 cents on sales of $10.83 million. Sales would be down 26.17 percent on a year-over-year basis. The company's reported EPS has stacked up against analyst estimates in the past like this:

 

Quarter

Q1 2019

Q4 2018

Q3 2018

Q2 2018

EPS Estimate

-0.4

-0.3

-0.33

-0.44

EPS Actual

-0.52

-0.37

-0.46

-0.46

Stock Performance

Over the last 52-week period, shares are up 14.01 percent. Given that these returns are generally positive, long-term shareholders are probably content going into this earnings release. Analysts' have adjusted their estimates lower for EPS and revenues over the past 90 days. Analysts have been rating Mitcham Industries stock as Sell. The strength of this rating has maintained conviction over the past three months.

See more from Benzinga

© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.